ZBIO vs UPB โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ZBIO Captures Institutional Edge (2โ1 Pillars ยท 5โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Zenas BioPharma, Inc. Common Stock (ZBIO) driven by superior Momentum & Technical, Options & Structure while UPB counters with relative strength in Growth & Margin. Fundamentally, ZBIO trades at N/M Forward P/E with -2747.5% operating margin (-100.0% YoY revenue) versus UPB at N/M Forward P/E and -6116.0% operating margin (-42.2% YoY). In options structure, ZBIO sits in CONSOLIDATION (13th %ile IV; Dealer Gamma Walls on Pro) against UPB sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ZBIO Revenue | UPB Revenue | ZBIO Op. Margin | UPB Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2023 | $50M | $0M | -74.3% | -1685.5% | ZBIO |
| FY2024 | $10M | $0M | -3277.8% | -3281.2% | ZBIO |
| FY2025 | $10M | $0M | -3830.6% | -5618.8% | ZBIO |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ZBIO | UPB | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.9B | $152.4M | Larger Scale | ZBIO |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -100.0% | -42.2% | Higher Growth | UPB |
| Operating Margin (TTM) Profitability | -2747.5% | -6116.0% | Higher Margin | ZBIO |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -265.1% | -53.5% | Higher ROE | UPB |
| 52-Week Range Position Momentum | 46% ($14โ$45) | 0% ($2โ$34) | Stronger Trend | ZBIO |
| Beta / 30D Volatility Risk Regime | 1.16ฮฒ ยท 59% Vol | 1.70ฮฒ ยท 120% Vol | Lower Realized Risk | ZBIO |
| Unified Institutional Score Composite Signal | 49.4 / 100 (HOLD) | 43.6 / 100 (HOLD) | Higher Composite | ZBIO |